Medical device stock CryoLife (CRY) has pre-announced below-consensus 1Q20 revenue of $65.5M, slightly below prior guidance of $67–69M.
Analyst Brooks West of Piper Jaffray reiterated his Overweight rating on Cryolife Inc (NYSE:CRY) with a price target of $16, marking a 21% …
